SANJEEV GUPTA, Sr. VP & Head-Advanced Biotech (Biosimilar), Ipca Laboratories

Sanjeev Gupta has obtained Ph.D. in Molecular Biology/Cell Line Engineering and M.Sc. in Applied Microbiology and Biotechnology. At present working as Vice President and Head, Advanced Biotech Lab (Biosimilar Division-R&D and Mfg.), Ipca Laboratories Ltd., Mumbai, India.

Dr. Gupta carries over 23 years of industrial experience and has been working since 2000 on the development of “Biosimilars” including monoclonal antibodies and other therapeutic proteins. His core expertise lies into Molecular Biology, Cell Line, Cell culture, Upstream process, Bio-analytical, Regulatory as well as Tech Transfer to the GMP for Clinical and Commercial manufacturing. He is also actively involved and contributing as a key Industry leader to re-form the new guideline in India (RCGM/CDSCO) and review committee member of BIRAC (Govt. of India). He is actively involved in dossier submission, approval and interaction with different regulatory agencies such as EMA, MHRA-UK, CDSCO and USFDA for Biosimilar launch in overseas markets

Till date, he developed and contributed for over Fifteen (15) recombinant molecules, of which Nine (09) biosimilars are already launched in the various markets and the rest are in the developmental or clinical phase, and are expected to be launched in near future.

He delivered talks on Biosimilars in various national and international conferences organized by IBC, Terrapin, BioTrain, IMAPAC, CphI, Biopharma, Informa and UBM. He also chaired/Moderated couple of sessions in international forums/platforms for conducting the biological conferences.

He has published several Research articles (13), Book chapters (06), Magazines (06) and Patent (01) in lieu of the Biosimilar development.

During his professional tenure, he worked at various position in reputed Indian biopharmaceuticals industries such as Zydus-Ahmedabad, Wockhardt-Aurangabad, Panacea-New Delhi, Intas-Ahmedabad and  at present with Ipca Laboratories, Mumbai.